K Number
K113422
Device Name
TERUMO SURGUARD 3 SAFETY NEEDLE TERUMO SURGUARD 3 HYPODERMIC SYRINGE WITH SAFETY NEEDLE
Date Cleared
2012-03-05

(105 days)

Product Code
Regulation Number
880.5570
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The TERUMO® SurGuard®3 Safety Needle device is intended for use in the aspiration and iniection of fluids for medical purposes. The TERUMO SurGuard 3 Safety Needle is compatible for use with standard luer slip and luer lock syringes. Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.
Device Description
The TERUMO SurGuard®3 Safety Needle consists of a hypodermic needle with a hinged safety sheath attached to the connector hub with or without an attached hypodermic syringe. This device features a hinged safety sheath attached to the needle hub. The safety sheath contains two locking mechanisms, the sheath tooth-cannula and sheath wings-collar which are simultaneously activated when manually pressed over the needle immediately after use and just prior to disposal to minimize the possibility of sharps injury. The safety sheath is activated with a one-handed operation by pressing the sheath either by finger or thumb, or by surface activation. The safety sheath has a finger guide area consisting of a circular dent (for thumb activation) and ramp (for finger activation) which gives the user a concrete confirmation that the user's finger is in the appropriate position in performing the activation. The ramp has steps to provide strong grasp when activating the sheath. There are two stoppers located at the end of the circular dent and ramp which assist in preventing the user's finger from going towards the cannula during activation. Another way of activation is by manually pressing the safety sheath over the needle using a firm surface. The locking mechanisms are positioned within the center and proximal end of the sheath. The hinge feature allows the medical practitioner to flexibly adjust the sheath to its desired position for use. The needle gauge sizes fall within the 18 to 25 gauge range and the needle lengths are 1" to 2". The TERUMO SurGuard®3 Safety Needle will be individually packaged and sterilized by electron beam as a safety needle only or as a safety needle with attached Terumo syringe. The syringe sizes are 3, 5, and 10cc/ml.
More Information

Not Found

No
The device description focuses on mechanical features for needle safety and does not mention any computational or data-driven components.

No.
The device is described as a safety needle for aspiration and injection of fluids, primarily focused on minimizing accidental needlesticks; it does not provide any therapeutic action itself.

No
The device is described as a safety needle for aspiration and injection of fluids, designed to minimize needlestick injuries, which are functions related to fluid transfer and safety, not diagnosis.

No

The device description clearly details physical components like a hypodermic needle, hinged safety sheath, connector hub, and potentially an attached syringe. It describes mechanical activation mechanisms and physical dimensions (gauge and length). This is a hardware device with a safety feature, not a software-only device.

Based on the provided information, the TERUMO® SurGuard®3 Safety Needle device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "aspiration and injection of fluids for medical purposes." This describes a device used directly on or in a patient for therapeutic or diagnostic procedures involving fluid transfer, not for testing samples in vitro (outside the body).
  • Device Description: The description details a hypodermic needle with a safety mechanism. This is a device for administering or withdrawing substances from the body, not for analyzing biological samples.
  • Lack of IVD Characteristics: The description does not mention any components or functions related to:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Detecting or measuring substances in samples
    • Performing diagnostic tests in vitro

The primary function of this device is to safely deliver or withdraw fluids from a patient and to prevent needlestick injuries after use. These are characteristics of a medical device used for direct patient care, not an IVD.

N/A

Intended Use / Indications for Use

The TERUMO® SurGuard®3 Safety Needle device is intended for use in the aspiration and injection of fluids for medical purposes. The TERUMO SurGuard®3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.

Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.

Product codes (comma separated list FDA assigned to the subject device)

80FMI / 80MEG

Device Description

The TERUMO SurGuard®3 Safety Needle consists of a hypodermic needle with a hinged safety sheath attached to the connector hub with or without an attached hypodermic syringe. This device features a hinged safety sheath attached to the needle hub. The safety sheath contains two locking mechanisms, the sheath tooth-cannula and sheath wings-collar which are simultaneously activated when manually pressed over the needle immediately after use and just prior to disposal to minimize the possibility of sharps injury. The safety sheath is activated with a one-handed operation by pressing the sheath either by finger or thumb, or by surface activation.

The safety sheath has a finger guide area consisting of a circular dent (for thumb activation) and ramp (for finger activation) which gives the user a concrete confirmation that the user's finger is in the appropriate position in performing the activation. The ramp has steps to provide strong grasp when activating the sheath. There are two stoppers located at the end of the circular dent and ramp which assist in preventing the user's finger from going towards the cannula during activation. Another way of activation is by manually pressing the safety sheath over the needle using a firm surface.

The locking mechanisms are positioned within the center and proximal end of the sheath. The hinge feature allows the medical practitioner to flexibly adjust the sheath to its desired position for use. The needle gauge sizes fall within the 18 to 25 gauge range and the needle lengths are 1" to 2".

The TERUMO SurGuard®3 Safety Needle will be individually packaged and sterilized by electron beam as a safety needle only or as a safety needle with attached Terumo syringe. The syringe sizes are 3, 5, and 10cc/ml.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K051865

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 880.5570 Hypodermic single lumen needle.

(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).

0

K113422

Terumo (Philippines) Corporation SurGuard3 Safety Needle 510k Section II 510k Summary

MAR - 5 2012

510(k) SUMMARY

Prepared for : TERUMO (PHILIPPINES) CORPORATION 124 East Main Avenue, Laguna Technopark, Binan, Laguna, Philippines

  • Prepared by : Ma. Cristina Faderagao - Supervisor Regulatory Affairs · Tel. (+63) 49 541 2111 Fax (+63) 49 541 2121
    Date prepared : December 21, 2011

Contact Person : Sandi Hartka

Regulatory Affairs Manager Terumo Medical Corporation 125 Blue Ball Road Elkton, MD 21921 Phone#: (410)392-7241 Fax#: (410)398-6079 E-mail: sandi.hartka@terumomedical.com

A. DEVICE NAME

Proprietary Name TERUMO® SurGuard®3 Safety Needle TERUMO® SurGuard®3 Hypodermic Syringe with Safety Needle

Classification Name Hypodermic Single Lumen Needle (880.5570) with antistick

Product Code: 80FMI / 80MEG Classification: Class II

Common Name

Hypodermic Needle with Safety Sheath or Needle with needle protection device.

1

B. INTENDED USE

The TERUMO® SurGuard®3 Safety Needle device is intended for use in the aspiration and injection of fluids for medical purposes. The TERUMO SurGuard®3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.

Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.

C. DEVICE DESCRIPTION

The TERUMO SurGuard®3 Safety Needle consists of a hypodermic needle with a hinged safety sheath attached to the connector hub with or without an attached hypodermic syringe. This device features a hinged safety sheath attached to the needle hub. The safety sheath contains two locking mechanisms, the sheath tooth-cannula and sheath wings-collar which are simultaneously activated when manually pressed over the needle immediately after use and just prior to disposal to minimize the possibility of sharps injury. The safety sheath is activated with a one-handed operation by pressing the sheath either by finger or thumb, or by surface activation.

The safety sheath has a finger guide area consisting of a circular dent (for thumb activation) and ramp (for finger activation) which gives the user a concrete confirmation that the user's finger is in the appropriate position in performing the activation. The ramp has steps to provide strong grasp when activating the sheath. There are two stoppers located at the end of the circular dent and ramp which assist in preventing the user's finger from going towards the cannula during activation. Another way of activation is by manually pressing the safety sheath over the needle using a firm surface.

The locking mechanisms are positioned within the center and proximal end of the sheath. The hinge feature allows the medical practitioner to flexibly adjust the sheath to its desired position for use. The needle gauge sizes fall within the 18 to 25 gauge range and the needle lengths are 1" to 2".

The TERUMO SurGuard®3 Safety Needle will be individually packaged and sterilized by electron beam as a safety needle only or as a safety needle with attached Terumo syringe. The syringe sizes are 3, 5, and 10cc/ml.

2

D. SUBSTANTIAL EQUIVALENCE

The TERUMO SurGuard 3 Safety Needle manufactured by Terumo Philippines Corporation is substantially equivalent in its intended use, technology/principal of operation, materials, and performance to the following cleared devices:

    1. K051865 TERUMO® SURGUARD2 TM SAFETY NEEDLE with or without syringe manufactured by Terumo (Philippines) Corporation.
      The proposed modifications to the device do not raise significant issues of safety and effectiveness.

E. SUMMARY OF TECHNOLOGICAL MODIFICATIONS

The TERUMO SurGuard®2 Safety Needle safety sheath was designed having one locking mechanism thru sheath tooth-cannula. The locking mechanism is located at a designated position within the body of the short or long sheath appropriate for the needle size it is to contain but with the proposed TERUMO SurGuard®3 Safety Needle safety sheath was designed having two locking mechanisms, the sheath tooth-cannula and sheath wings-collar. The locking mechanisms are positioned within the center and proximal end of the sheath.

The differences in the design made to the proposed TERUMO SurGuard®3 Safety Needle in comparison to the cleared TERUMO SurGuard®2 Safety Needle will increase the number of ways to activate the safety feature. The cleared TERUMO SurGuard®2 Safety Needle is activated only by manually pressing the sheath over the needle using a firm surface whereas the proposed TERUMO SurGuard®3 Safety Needle is activated by three methods; by pressing the sheath either by finger or by thumb, or by surface activation.

The TERUMO SurGuard®2 Safety Needle gauge sizes fall within the 18 to 30 gauge range and the needle lengths are 3/8" to 1 ½" whereas the TERUMO SurGuard®3 Safety Needle gauge sizes fall within the 18 to 25 gauge range and the needle lengths are 1" to 2".

The TERUMO SurGuard®2 Safety Needle syringe sizes are 1, 3, 5, and 10cc/ml. The TERUMO SurGuard®3 Safety Needle syringes will be available in 3, 5, and 10cc/ml.

3

Terumo (Philippines) Corporation SurGuard3 Safety Needle 510k Section II 510k Summary

F. Additional Safety Information

Manufacturing controls include visual, functional and sterility tests.

The sterility of the device is assured using a sterilization method validated in accordance with ANSI/AAMI/ISO 11137 - Medical Devices - Validation and Routine Control of Radiation Sterilization. The TERUMO SurGuard® 3 Safety Needle is sterilized to provide a Sterility Assurance Level (SAL) of 10-6.

The TERUMO SurGuard®3 Safety Needle is classified as Externally Communicating Device, Circulating Blood, Limited Duration of Contact (≤24hr.). The device's blood contacting materials were tested in accordance with the tests recommended in the FDA General Program Memorandum #G95-1 (5/1/95): Use of International Standard ISO - 10993, "Biological Evaluation of Medical Devices part 1: Evaluation and Testing". Results of the testing demonstrate that the blood contacting materials are biocompatible.

G. Conclusion

In summary, the TERUMO SurGuard®3 Safety Needle manufactured by Terumo Philippines Corporation is substantially equivalent in its intended use, technology/principal of operation, materials, and performance to the following cleared devices:

    1. K051865 TERUMO® Surguard TM SAFETY NEEDLE with or without syringe manufactured by Terumo (Philippines) Corporation.
      The modifications made to the devices covered in K051865 do not raise new issues of safety or effectiveness nor do they affect the intended use/indications for use.

Terumo's statement of substantial equivalence is done solely to comply with the requirements of the Federal Food, Drug and Cosmetic Act and is not intended whatsoever to be the basis for a patent infringement action.

4

Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight, composed of three curved lines.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Ms. Sandi Hartka Manager Regulatory Affairs Terumo Philippines Corporation 950 Elkton Boulevard Elkton, Maryland 21921

MAR - 5 2012

Re: K113422

Trade/Device Name: TERUMO® SurGuard®3 Safety Needle and TERUMO® SurGuard Hypodermic Syringe with Safety Needle Regulation Number: 21 CFR 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: FMI, MEG Dated: February 3, 2012 Received: February 6, 2012

Dear Ms. Hartka:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Eederal Register.

5

Page 2- Ms. Hartka

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices /ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours.

ef

Anthony D. Watson, B.S., M.S., M.B.A. Director

Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

6

Indications for Use

510(k) Number (if known):K113422
------------------------------------
Device Name:TERUMO® SurGuard®3 Safety Needle and
TERUMO® SurGuard®3 Hypodermic Syringe with Safety Needle

Indications For Use:

The TERUMO® SurGuard®3 Safety Needle device is intended for use in the aspiration and iniection of fluids for medical purposes. The TERUMO SurGuard 3 Safety Needle is compatible for use with standard luer slip and luer lock syringes.

Additionally, after withdrawal of the needle from the body, the attached needle safety shield can be manually activated to cover the needle immediately after use to minimize risk of accidental needlestick.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

: Graggi

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)

Division of Anesthesiology, General Hospital fection Control, Dental Devices

510(k) Number: K113422